Clinical Trial Update: Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for INDICT studying depolarization-inhibition with combination therapy in traumatic brain injury; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: University of Cincinnati | Conditions: Traumatic Brain Injury | Phase 2 | Status: RECRUITING